grey semaglutide DEXA Scan Becky's 45-Pound Transformation: How Semaglutide

Understanding GLP-1s for Diabetes, Weight Loss, and Beyond Novo Nordisk's Ozempic Pill, the Only FDA-Approved Oral Peptide GLP-1 Medication for Adults With Type 2 diabetes, Soon to Be Available in the US

doi: 10.1016/j.immuni.2014.06.005 127 IbitokouSADillonBESinhaMSzczesnyBDelgadilloAReda AbdelrahmanDet al

For instance, in clinical trials, Retatrutide achieved up to a 24.2% reduction in body weight over 48 weeks, whereas Tirzepatide users saw an average weight loss of 19.5% and 20.9% after 72 weeks of treatment (10-mg and 15-mg dose, respectively)

Blonde L, Raccah D, Lew E, et al

2023 [cited 2026 Feb 11];57:11120